Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Gilead Sciences to Present at the 29th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 11


Print article Print article
© Business Wire 2008
2008-06-04 23:44:28 -

www.gilead.com - Gilead Sciences, Inc. Susan Hubbard, 650-522-5715 (Investor Relations) Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate presentation will be webcast from the 29th Annual Goldman Sachs Global Healthcare Conference in Dana Point, CA.

John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company on Wednesday, June 11 at 2:40 p.m. Pacific Time (5:40 p.m. Eastern Time).

To access the live webcast via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences

is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Webcast Available Through Gilead Corporate Website


Author:
Hossam Abdel-Kader
e-mail
Web: www.pr-inside.com/
Phone: +43 1 9582319

Disclaimer: (c) 2012 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser